Novavax (NVAX) Misses Q1 EPS by 13c; Offers FY22 Revenue Guidance
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $9.13 -3.89%
Revenue Growth %: -78.2%
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: -78.2%
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q1 EPS of $2.56, $0.13 worse than the analyst estimate of $2.69. Revenue for the quarter came in at $704 million versus the consensus estimate of $845.2 million.
GUIDANCE:
Novavax sees FY2022 revenue of $4-5 billion.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
- Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
- Hyperscale Data launches $300M at-the-market stock offering
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
